Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation
- 13 September 2016
- journal article
- other
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 132 (5), 757-760
- https://doi.org/10.1007/s00401-016-1616-3
Abstract
No abstract availableFunding Information
- National Cancer Institute (P50 CA097257)
- National Institute of Neurological Disorders and Stroke (NS081117)
- Pediatric Brain Tumor Foundation
This publication has 7 references indexed in Scilit:
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas—Same Entity or First Cousins?Brain Pathology, 2015
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersActa Neuropathologica, 2015
- The landscape of kinase fusions in cancerNature Communications, 2014
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian CancerCancer Research, 2011
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaActa Neuropathologica, 2011
- The Human Homolog of Saccharomyces cerevisiae Apg7p Is a Protein-activating Enzyme for Multiple Substrates Including Human Apg12p, GATE-16, GABARAP, and MAP-LC3Journal of Biological Chemistry, 2001